Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease

Journal of Neuro-Oncology

Volumn 131, Issue 2, 2017, Pages 233-244

  Mallawaaratchy, Duthika M ^a   Hallal, Susannah ^a,b   Russell, Ben ^a,b   Ly, Linda ^a   Ebrahimkhani, Saeideh ^a,b   Wei, Heng ^a,c   Christopherson, Richard I ^a   Buckland, Michael E ^a,b,c   Kaufman, Kimberley L ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Annexin a1; Exosome; Extracellular vesicle; Glioblastoma; Invadopodia; Proteomics

Indexed keywords

ACTIN RELATED PROTEIN 3; BETA1 INTEGRIN; LIPOCORTIN 1; PROTEOME; SOMATOMEDIN B RECEPTOR; TUMOR MARKER;

ACTIN POLYMERIZATION; ACTIN RELATED PROTEIN 3 GENE; ANNEXIN A1 GENE; ARTICLE; CARCINOGENESIS; CELL INVASION; CELL LEVEL; COHORT ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; EXOSOME; GENE FUNCTION; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN LIKE GROWTH FACTOR 2 RECEPTOR GENE; INTEGRIN BETA1 GENE; MASS SPECTROMETRY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; ONCOGENE; PROGRAMMED CELL DEATH 6 INTERACTING PROTEIN GENE; PROTEOMICS; QUANTITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; BRAIN TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL LINE, TUMOR; EXTRACELLULAR VESICLES; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; PROTEOME; PROTEOMICS;

EID: 84992065779     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-016-2298-3     Document Type: Article

References (69)

1. Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569–579
2. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200(4):373–383
3. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr., Carter BS, Krichevsky AM, Breakefield XO (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470–1476
4. Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringner M, Morgelin M, Bourseau-Guilmain E, Bengzon J, Belting M (2013) Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. PNAS 110(18):7312–7317
5. Antonyak MA, Li B, Boroughs LK, Johnson JL, Druso JE, Bryant KL, Holowka DA, Cerione RA (2011) Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 108(12):4852–4857
6. Lo Cicero A, Schiera G, Proia P, Saladino P, Savettieri G, C.M. Di Liegro, Di Liegro I (2011) Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes. Int J Oncol 39:1353–1357
7. Redzic JS, Ung TH, Graner MW (2014) Glioblastoma extracellular vesicles: reservoirs of potential biomarkers. Pharmacogenomics and Personalized. Medicine (Baltimore) 7:65–77
8. Li CC, Eaton SA, Young PE, Lee M, Shuttleworth R, Humphreys DT, Grau GE, Combes V, Bebawy M, Gong J, Brammah S, Buckland ME, Suter CM (2013) Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol 10(8):1333–1344
9. Bolukbasi MF, Mizrak A, Ozdener GB, Madlener S, Strobel T, Erkan EP, Fan JB, Breakefield XO, Saydam O (2012) miR-1289 and “Zipcode"-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids 1:e10
10. Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchelle DA, Bigner DD (2009) Proteomic and immunlogica analyses of brain tumor exosomes. FASEB J 23:1541–1557
11. de Vrij J, Maas SL, Kwappenberg KM, Schnoor R, Kleijn A, Dekker L, Luider TM, de Witte LD, Litjens M, van Strien ME, Hol EM, Kroonen J, Robe PA et al (2015) Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer 137(7):1630–1642
12. Mallawaaratchy DM, Buckland ME, McDonald KL, Li CC, Ly L, Sykes EK, Christopherson RI, Kaufman KL (2015) Membrane proteome analysis of glioblastoma cell invasion. J Neuropathol Exp Neurol 74(5):425–441
13. Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, Tyska MJ, Weaver AM (2013) Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep 5(5):1159–1168
14. Schlienger S, Campbell S, Claing A (2014) ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion. Mol Biol Cell 25(1):17–29
15. Havrylov S, Park M (2015) MS/MS-based strategies for proteomic profiling of invasive cell structures. Proteomics 15(2–3):272–286
16. Fasano VA, Zeme S, Frego L, Gunetti R (1981) Ultrasonic aspiration in the surgical treatment of intracranial tumors. J Neurosurg Sci 25(1):35–40
17. Day BW, Stringer BW, Wilson J, Jeffree RL, Jamieson PR, Ensbey KS, Bruce ZC, Inglis P, Allan S, Winter C, Tollesson G, Campbell S, Lucas P et al (2013) Glioma surgical aspirate: a viable source of tumor tissue for experimental research. Cancers (Basel) 5(2):357–371
18. Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borras FE, Breakefield X, Budnik V, Buzas E, Camussi G, Clayton A et al (2012) Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 10(12):e1001450
19. Palazzolo G, Albanese NN, Cara GD, Gygax D, Vittorelli ML, I (2012) Pucci-Minafra, proteomic analysis of exosome-like vesicles derived from breast cancer cells. Anticancer Res 32(3):847–860
20. Witwer, KW, Buzas EI, Bemis LT, Bora A, Lasser C, Lotvall J, Nolte-’t Hoen EN, Piper MG, Sivaraman S, Skog J, Thery C, Wauben MH, Hochberg F (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2. doi:10.3402/jev.v2i0.20360
21. MacDonald C, Buchkovich NJ, Stringer DK, Emr SD, Piper RC (2012) Cargo ubiquitination is essential for multivesicular body intralumenal vesicle formation. EMBO Rep 13(4):331–338
22. Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR (2009) Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res 8(3):1304–1314
23. Capriotti AL, Caruso G, Cavaliere C, Piovesana S, Samperi R, Lagana A (2013) Proteomic characterization of human platelet-derived microparticles. Anal Chim Acta 776:57–63
24. Al Kaabi A, Traupe T, Stutz M, Buchs N, Heller M (2012) Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy. PLoS One 7(10):e46822
25. de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, Schiffelers RM, Gucek M, van Balkom BW (2012) Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles 1. doi:10.3402/jev.v1i0.18396
26. Pallet N, Sirois I, Bell C, Hanafi LA, Hamelin K, Dieude M, Rondeau C, Thibault P, Desjardins M, Hebert MJ (2013) A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells. Proteomics 13(7):1108–1120
27. Nana AW, Yang PM, Lin HY (2015) Overview of transforming growth Factor beta superfamily involvement in glioblastoma initiation and progression. Asian Pac J Cancer Prev 16(16):6813–6823
28. Nagato S, Nakagawa K, Harada H, Kohno S, Fujiwara H, Sekiguchi K, Ohue S, Iwata S, Ohnishi T (2005) Downregulation of laminin alpha4 chain expression inhibits glioma invasion in vitro and in vivo. Int J Cancer 117(1):41–50
29. Thomas SL, Alam R, Lemke N, Schultz LR, Gutierrez JA, Rempel SA (2010) PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling. Neuro Oncol 12(9):941–955
30. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O’Kelly M et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98–110
31. Nakahara H, Mueller SC, Nomizu M, Yamada Y, Yeh Y, Chen WT (1998) Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia. J Biol Chem 273(1):9–12
32. Destaing O, Planus E, Bouvard D, Oddou C, Badowski C, Bossy V, Raducanu A, Fourcade B, Albiges-Rizo C, Block MR (2010) beta1A integrin is a master regulator of invadosome organization and function. Mol Biol Cell 21(23):4108–4119
33. Schaffner F, Ray A, Dontenwill M (2013) Integrin α5β1, the fibronectin receptor, as a pertinent therapeutic target in solid tumors. Cancers 5(1):27–47
34. Ozerlat I (2010) Cell migration: ESCRTing integrin degradation. Nat Rev Mol Cell Biol 11(9):602–603
35. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, Condeelis J (2005) Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 168(3):441–452
36. Rotty JD, Wu C, Bear JE (2013) New insights into the regulation and cellular functions of the ARP2/3 complex. Nat Rev Mol Cell Biol 14(1):7–12
37. Riches A, Campbell E, Borger E, Powis S (2014) Regulation of exosome release from mammary epithelial and breast cancer cells—a new regulatory pathway. Eur J Cancer 50(5):1025–1034
38. Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S, Hodge JW (2014) Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget 5:403–416
39. 2+ influx. J Biol Chem 271(16):9332–9339
40. Savina A, Furlán M, Vidal M, C MI (2003) Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem 278(22):20083–20090
41. Yu Z, Fotouhi-Ardakani N, Wu L, Maoui M, Wang S, Banville D, Shen SH (2002) PTEN associates with the vault particles in HeLa cells. J Biol Chem 277(43):40247–40252
42. Berger W, Steiner E, Grusch M, Elbling L, Micksche M (2009) Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci 66(1):43–61
43. Lotsch D, Steiner E, Holzmann K, Spiegl-Kreinecker S, Pirker C, Hlavaty J, Petznek H, Hegedus B, Garay T, Mohr T, Sommergruber W, Grusch M, Berger W (2013) Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis. Oncotarget 4(11):1904–1918
44. Shi F, Shang L, Pan BQ, Wang XM, Jiang YY, Hao JJ, Zhang Y, Cai Y, Xu X, Zhan QM, Wang MR (2014) Calreticulin promotes migration and invasion of esophageal cancer cells by upregulating neuropilin-1 expression via STAT5A. Clin Cancer Res 20(23):6153–6162
45. Okunaga T, Urata Y, Goto S, Matsuo T, Mizota S, Tsutsumi K, Nagata I, Kondo T, Ihara Y (2006) Calreticulin, a molecular chaperone in the endoplasmic reticulum, modulates radiosensitivity of human glioblastoma U251MG cells. Cancer Res 66(17):8662–8671
46. Raghavan M, Wijeyesakere SJ, Peters LR, Del Cid N (2013) Calreticulin in the immune system: ins and outs. Trends Immunol 34(1):13–21
47. Johnson RJ, Xiao G, Shanmugaratnam J, Fine RE (2001) Calreticulin functions as a molecular chaperone for the beta-amyloid precursor protein. Neurobiol Aging 22(3):387–395
48. Culicchia F, Cui JG, Li YY, Lukiw WJ (2008) Upregulation of beta-amyloid precursor protein expression in glioblastoma multiforme. Neuroreport 19(9):981–985
49. Perez-Gonzalez R, Gauthier SA, Kumar A, Levy E (2012) The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space. J Biol Chem 287(51):43108–43115
50. Okabayashi S, Kimura N (2010) LGI3 interacts with flotillin-1 to mediate APP trafficking and exosome formation. NeuroReport 21(9):606–610
51. Nelson JS (2002) Alzheimer pathology in elderly patients with glioblastoma multiforme. Arch Pathol Lab Med 126:1515–1517
52. McDonald KL, O’Sullivan MG, Parkinson JF, Shaw JM, Payne CA, Brewer JM, Young L, Reader DJ, Wheeler HT, Cook RJ, Biggs MT, Little NS, Teo C et al (2007) IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients. J Neuropathol Exp Neurol 66(5):405–417
53. Lemamy G, Sahla M, Berthe M, Roger P (2008) Is the mannose-6-phosphate/insulin-like growth factor 2 receptor coded by a breast cancer suppressor gene?. In: Li VJ et al (eds) Hormonal Carcinogenesis. Springer New York, p. 305–310
54. Probst OC, Puxbaum V, Svoboda B, Leksa V, Stockinger H, Mikula M, Mikulits W, Mach L (2009) The mannose 6-phosphate/insulin-like growth factor II receptor restricts the tumourigenicity and invasiveness of squamous cell carcinoma cells. Int J Cancer 124(11):2559–2567
55. Liu Y, Zhou Y, Zhu K (2012) Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion. PLoS One 7(9):e45910
56. Dolo V, D’Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S, Pavan A (1999) Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 17(2):131–140
57. Barh D, Carpi A, Verma M, Gunduz M (2014) Cancer biomarkers: minimal and noninvasive early diagnosis and prognosis. CRC Press
58. Fukuda ME, Iwadate Y, Machida T, Hiwasa T, Nimura Y, Nagai Y, Takiguchi M, Tanzawa H, Yamaura A, Seki N (2005) Cathepsin d is a potential serum marker for poor prognosis in glioma patients. Cancer Res 65(12):5190–5194
59. Gu M, Guan J, Zhao L, Ni K, Li X, Han Z (2013) Correlation of ECM1 expression level with the pathogenesis and metastasis of laryngeal carcinoma. Int J Clin Exp Pathol 6(6):1132–1137
60. Wu Q, Li X, Yang H, Lu C, You J, Zhang Z (2014) Extracellular matrix protein 1 is correlated to carcinogenesis and lymphatic metastasis of human gastric cancer. World J Surg Oncol 12:132
61. Wang L, Yu J, Ni J, Xu XM, Wang J, Ning H, Pei XF, Chen J, Yang S, Underhill CB, Liu L, Liekens J, Merregaert J et al (2003) Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Lett 200(1):57–67
62. Lal G, Hashimi S, Smith BJ, Lynch CF, Zhang L, Robinson RA, Weigel RJ (2009) Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a hospital-based cohort study in Iowa. Ann Surg Oncol 16(8):2280–2287
63. Gygi SP, Rochon Y, Franza BR, Aebersold R (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19(3):1720–1730
64. Anderson L, Seilhamer J (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18(3–4):533–537
65. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1(11):845–867
66. Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9(8):581–593
67. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, Rosenblum M, Mikkelsen T, Fine HA (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9(4):287–300
68. The Cancer Genome Atlas Homepage. TCGA Research Network [Webpage], Retreived 22, August, 2014 from: http://cancergenome.nih.gov/
69. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC, Hainfellner JA, Heppner FL, Dietrich PY et al (2008) Stem cell-related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 26(18):3015–3024